DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Definium Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$32.97+0.87 (+2.71%)

Close on Oct 19, 2026

Market cap: $3.65B
P/E (TTM): –
Dividend yield: –

Definium Therapeutics, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Research & Development	118	65	52	36	35	19	–
General & Administrative	49	39	42	30	59	14	–
Operating Expenses	166	104	94	66	94	33	–
Operating Income	-166	-104	-94	-66	-94	-33	–
Interest Expense	5.48	2.28	0.92	–	–	–	–
Interest & Investment Income	11	12	5.58	–	–	–	–
Other Non-Operating Income	-17	-4.76	-1.87	9.54	-0.34	-0.91	–
Asset Impairment Charges	0	0	0	0	0	–	–
Pretax Income	-184	-109	-96	-57	-94	-34	-11
Income Tax Expense	0	–	–	–	-1.16	–	–
Net Income incl. Noncontrolling Interests	-184	-109	-96	-57	-93	-34	–
Net Income	-184	-109	-96	-57	-93	-34	–
Net Income to Common	-184	-109	–	–	–	–	–
EPS (Basic)(per share)	-2.06	-1.54	-2.44	-1.84	-3.40	-1.95	–
EPS (Diluted)(per share)	-2.06	-1.54	-2.44	-1.84	-3.40	-1.95	–
Shares Outstanding (Basic, Weighted)(shares)	89	70	39	31	27	18	–
Shares Outstanding (Diluted, Weighted)(shares)	89	70	39	31	27	18	–
Net Interest Income	–	–	4.66	1.50	-0.36	-0.16	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -64.1%

Financial strength

Current ratio: 6.95
Debt to equity: 0.04
Debt to assets: 3.3%
Cash to current liabilities: 416.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 3.97
Dividend yield: –